These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 22684992)

  • 1. Investigation of serum proteome alterations in human glioblastoma multiforme.
    Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
    Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response.
    Ray S; Kamath KS; Srivastava R; Raghu D; Gollapalli K; Jain R; Gupta SV; Ray S; Taur S; Dhali S; Gogtay N; Thatte U; Srikanth R; Patankar S; Srivastava S
    J Proteomics; 2012 Jun; 75(10):3063-80. PubMed ID: 22086083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
    Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
    Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic identification of haptoglobin α2 as a glioblastoma serum biomarker: implications in cancer cell migration and tumor growth.
    Kumar DM; Thota B; Shinde SV; Prasanna KV; Hegde AS; Arivazhagan A; Chandramouli BA; Santosh V; Somasundaram K
    J Proteome Res; 2010 Nov; 9(11):5557-67. PubMed ID: 20822092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of serum proteome alterations in human endometriosis.
    Dutta M; Subramani E; Taunk K; Gajbhiye A; Seal S; Pendharkar N; Dhali S; Ray CD; Lodh I; Chakravarty B; Dasgupta S; Rapole S; Chaudhury K
    J Proteomics; 2015 Jan; 114():182-96. PubMed ID: 25449831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS].
    Liao QL; Chen XD; Zhao L; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):154-8. PubMed ID: 18250030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screen and identify of differential proteins expressed in the placenta of Down's syndrome].
    Yan LY; Sun CJ; Wang X; Chen Y; Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):161-6. PubMed ID: 21575446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network generation enhances interpretation of proteomics data sets by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry.
    Wang X; Zhang A; Sun H; Wu G; Sun W; Yan G
    Analyst; 2012 Oct; 137(20):4703-11. PubMed ID: 22950079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
    Leong S; McKay MJ; Christopherson RI; Baxter RC
    J Proteome Res; 2012 Feb; 11(2):1240-50. PubMed ID: 22133146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
    Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
    Vogel TW; Zhuang Z; Li J; Okamoto H; Furuta M; Lee YS; Zeng W; Oldfield EH; Vortmeyer AO; Weil RJ
    Clin Cancer Res; 2005 May; 11(10):3624-32. PubMed ID: 15897557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the raw serum peptidomic pattern in glioma patients.
    Li Z; Lu H; Yang J; Zeng X; Zhao L; Li H; Liao Q; Peng S; Zhou M; Wu M; Xiang J; Wang Y; Li G
    Clin Chim Acta; 2013 Oct; 425():221-6. PubMed ID: 23954773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus.
    Huang Z; Shi Y; Cai B; Wang L; Wu Y; Ying B; Qin L; Hu C; Li Y
    Rheumatology (Oxford); 2009 Jun; 48(6):626-31. PubMed ID: 19389822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
    Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
    Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
    Guidi F; Puglia M; Gabbiani C; Landini I; Gamberi T; Fregona D; Cinellu MA; Nobili S; Mini E; Bini L; Modesti PA; Modesti A; Messori L
    Mol Biosyst; 2012 Apr; 8(4):985-93. PubMed ID: 22134777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of differentially expressed proteins involved in hand, foot and mouth disease and normal sera.
    Deng L; Jia HL; Liu CW; Hu KH; Yin GQ; Ye JW; He CH; Chen JH; Xie YP; Dang R; Zhang L; Liu NY; Zhu L; Zhang L
    Clin Microbiol Infect; 2012 Jun; 18(6):E188-96. PubMed ID: 22497606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.